Unchained Labs. (6/29/17). "Press Release: Unchained Labs Racks Up another One, Acquires Trinean!". Pleasanton, CA.

	Organisation	Unchained Labs (US)
	Group	Unchained Labs (Group)
	Organisation 2	Trinean N.V.
	Today	Unchained Labs Belgium
	Group	Unchained Labs (Group)
	Product	DropSense96® multichannel spectrophotometer
	Product 2	laboratory equipment and instruments
	Index term	Trinean–Unchained Labs: investment, 201706 acquisition of Trinean by Unchained Labs
	Index term 2	Unchained Labs–SEVERAL: investment, 201706 financing round Series C $13m incl existing investors Novo Ventures + Canaan Partnes + TPG Biotech
	Person	Stas, Philippe (Trinean 201204– CEO before Lonza + AlgoNomics 200712–2009 CEO + PerkinElmer + KeyGene)
	Person 2	Harkness, Tim (Cell Biosciences 200909 CEO)

Unchained Labs, the life sciences company that's all about getting biologics researchers the right tool for the job, acquired Trinean today. Trinean's DropSense systems measure protein, DNA and RNA concentration in biologics and genomics samples. This is Unchained Labs' 5th acquisition in just over 2 years.

DropSense96 is the only system out there that can measure up to 96 high concentration protein samples in 5 minutes. Scientists just load 2 microliters of sample into the proprietary DropPlate, put it in the system and that's it. DropSense systems are a completely worry-free way to measure concentrations — no need to dilute or mix samples, clean anything before or after a run, or calibrate the system.

"Since it started 10 years ago, Trinean has made micro-volume concentration measurements higher throughput and more accessible to life science researchers," said Philippe Stas, CEO of Trinean. "Unchained Labs is the ideal home for DropSense and this acquisition is great for our customers, partners and employees."

"These products are a perfect strategic fit for Unchained Labs," said Tim Harkness, Founder and CEO of Unchained Labs. "Concentration measurement is central to everything our customers do and DropSense96 is the only product in the world that does it for biologics at high concentration with high-throughput."

In just over 2 years, Unchained Labs has grown to over 130 employees, $35M+ in revenue, 8 product lines and has direct distribution around the world. In connection with this transaction, the company raised $13M in a Series C financing. The original syndicate partners, Novo Ventures, Canaan Partners and TPG Biotech all participated in the financing.

About Unchained Labs

Here's the deal. We're all about helping biologics researchers break free from tools that just don't cut it. Unleashing problem-tackling products that make a huge difference in the real science they do every day. That's our mantra, our promise and we own it. We're located in Pleasanton, CA and can be found online at www.unchainedlabs.com.

Contact:

Taegen Clary
VP of Marketing, Unchained Labs
taegen.clary@unchainedlabs.com
925.587.9806

Record changed: 2023-06-05

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]